# Nitrosamines impurities in medicines

Source: https://www.keypedia.com/records/uk_mhra_guidance/uk-mhra/bfd824d7-8986-4c81-a93a-955a2050dc0d
Type: Guidance
Published: August 24, 2023

> Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.

---

## Content

The Medicines and Healthcare products Regulatory Agency (MHRA) has assessed the risk of nitrosamine formation or presence during the manufacture of human medicines and has provided guidance for manufacturers to avoid the presence of nitrosamine impurities.

## Attachments

- [Nitrosamines impurities in medicines](/government/publications/nitrosamines-impurities-in-medicines/nitrosamines-impurities-in-medicines)